Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Phase 1b Dose Escalation Study of BI 836858 and Azacitidine in Previously Untreated AML: Results from Beat AML S2

Blood (2018) 132 (Supplement 1): 4053.

https://doi.org/10.1182/blood-2018-99-116199

Published: 2018

Journal Articles

Coupling Therapeutics to Human Erythrocytes Demonstrates Target-Dependent Effects on Red Cell Physiology While Preserving Efficacy

Carlos Hipolito Villa, MD PhD, Daniel Pan, PhD, Ian Johnston, BS, Colin F Greineder, MD PhD, Marion E. Reid, PhD, Douglas B. Cines, MD, Mortimer Poncz, MD, Don L. Siegel, MD, PhD,, Vladimir R Muzykantov, MD PhD

Blood (2016) 128 (22): 701.

https://doi.org/10.1182/blood.V128.22.701.701

Published: 2016

Journal Articles

Clinical Exome Sequencing Unravels New Disease Causing Mutations in Myeloproliferative Neoplasms (MPNs): A Pilot Study in Patients from the State of Qatar

Mohamed A. Yassin, MBBS, MSc, CABM, FACP, Nader I Al-Dewik, BSc, MSc, PhD

Blood (2016) 128 (22): 5520.

https://doi.org/10.1182/blood.V128.22.5520.5520

Published: 2016

Journal Articles

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

Blood (2016) 128 (2): 297–312.

https://doi.org/10.1182/blood-2016-03-706317

Published: 2016

Includes: Supplemental data

Journal Articles

Analysis of WT1 Mutations and Combined Aberrations in Childhood Acute Myeloid Leukemia using Whole Exome Sequencing

Nils von Neuhoff, PhD, Peter Husemann, PhD, Robert Geffers, PhD, Christiane Walter, M.Sc., Christine von Neuhoff, MD, Martin Zimmermann, PhD, Brigitte Schlegelberger, MD, Dirk Reinhardt, MD PhD

Blood (2014) 124 (21): 2340.

https://doi.org/10.1182/blood.V124.21.2340.2340

Published: 2014

Journal Articles

Results of an AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Randomized Clinical Trial in Children with Low- and Intermediate-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Franco Locatelli, Marco Zecca, MD, Gianni Cazzaniga, PhD, Luciana Vinti, MD, Andrea Biondi, Tommaso Mina, MD, Chiara Messina, Rosanna Parasole, Franca Fagioli, MD, Ottavio Ziino, Giuseppe Basso, MD, Riccardo Masetti, MD, Carmelo Rizzari

Blood (2014) 124 (21): 65.

https://doi.org/10.1182/blood.V124.21.65.65

Published: 2014

Journal Articles

Dual functions of cell-autonomous and non–cell-autonomous ADAM10 activity in granulopoiesis

Masaki Yoda, Tokuhiro Kimura, Takahide Tohmonda, Shinichi Uchikawa, Takeshi Koba, Jiro Takito, Hideo Morioka, Morio Matsumoto, Daniel C. Link, Kazuhiro Chiba, Yasunori Okada, Yoshiaki Toyama, Keisuke Horiuchi

Blood (2011) 118 (26): 6939–6942.

https://doi.org/10.1182/blood-2011-06-357210

Published: 2011

Includes: Supplemental data

Journal Articles

Excellent Prognosis of Late Relapses of ETV6/RUNX1 Childhood Acute Lymphoblastic Leukemia: Lessons From the FRALLE 93 Protocol

Virginie Gandemer, MD, PhD, Sylvie Chevret, Arnaud Petit, Christiane Vermylen, MD, PhD, Thierry Leblanc, MD, Gerard Michel, Claudine Schmitt, Odile Lejars, Jean-Pierre Vannier, Francois Demeocq, Brigitte Bader-Meunier, Francoise Bernaudin, Yves Perel, MD, PhD, Marie-Francoise Auclerc, Jean Michel Cayuela, MD, PhD, Guy Leverger, MD, PhD, Andre Baruchel

Blood (2011) 118 (21): 1508.

https://doi.org/10.1182/blood.V118.21.1508.1508

Published: 2011

Journal Articles

Inotuzumab Ozogamycin (I0), a CD22 Monoclonal Antibody Conjugated to Calecheamicin, Is Active in Refractory-Relapse Acute Lymphocytic Leukemia (R-R ALL)

Susan o'Brien, Deborah A. Thomas, MD, Maro Ohanian, M.D., Jeffrey L. Jorgensen, MD, PhD, Partow Kebriaei, MD, Elias Jabbour, Michael E. Rytting, MD, Sergernne York, RN, Farhad Ravandi, MD, Monica Kwari, BSN, Stefan Faderl, MD, Mary Beth Rios, RN, Jorge E. Cortes, Luis Fayad, MD, Robert Tarnai, MT, Sa A. Wang, MD, Richard Champlin, MD, Anjali S. Advani, MD, Hagop M. Kantarjian

Blood (2011) 118 (21): 875.

https://doi.org/10.1182/blood.V118.21.875.875

Published: 2011

Journal Articles

Glycoprotein Ibalpha Inhibitor Complex Crystal Structure at High Resolution.

P.A Mcewan, Bsc, Phd, Robert K Andrews, Ph.D, Jonas Emsley, Bsc, Phd

Blood (2009) 114 (22): 774.

https://doi.org/10.1182/blood.V114.22.774.774

Published: 2009

Journal Articles

Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors

Yenan T. Bryceson, Hans-Gustaf Ljunggren, Eric O. Long

Blood (2009) 114 (13): 2657–2666.

https://doi.org/10.1182/blood-2009-01-201632

Published: 2009

Includes: Supplemental data

Journal Articles

Molecular Response to Treatment Predicts Outcome in Isolated, but Not in Combined Bone Marrow Relapses of Childhood Acute Lymphoblastic Leukaemia: Interim Results of Trial ALL-REZ BFM 2002

Cornelia Eckert, PhD, Arend Stackelberg, MD, Nikola Hagedorn, Andrea Barth, Karl Seeger, MD, PhD, Guenter Henze, MD

Blood (2008) 112 (11): 2515.

https://doi.org/10.1182/blood.V112.11.2515.2515

Published: 2008

Journal Articles

Structural and Functional Investigations of Active Site Binding Regions in Factor VIIa.

S. Paul Bajaj, Amanda Sutton, Sreejesh Shanker, Amy E Schmidt, Sayeh Agah, William H Velander, Kaillathe Padmanabhan, Duilio Cascio

Blood (2008) 112 (11): 2029.

https://doi.org/10.1182/blood.V112.11.2029.2029

Published: 2008

Journal Articles

Variants of Recombinant Factor IX with Enhanced Functional Properties.

Rudolf Hartmann, PhD, Michael Dockal, PhD, Willibald Kammlander, Erwin Panholzer, Friedrich Scheiflinger, PhD

Blood (2007) 110 (11): 2694.

https://doi.org/10.1182/blood.V110.11.2694.2694

Published: 2007

Journal Articles

Influence of Multimer Size and a Natural Dimorphism on the Activity of Convulxin.

Kazunobu Kato, M.D., Ph.D., Yann Cheli, Kenichi Furihata, M.D., Ph.D., Gandhi Radis-Baptista, Ph.D., Thomas J. Kunicki, Ph.D.

Blood (2004) 104 (11): 3927.

https://doi.org/10.1182/blood.V104.11.3927.3927

Published: 2004

Journal Articles

Proliferation Characteristics in Pediatric Hodgkin’s Disease Point to a Cell Cycle Arrest in G 1 Phase.

Markus Tiemann, MD, Alexander Claviez, MD, Heike Lueders, Martin Zimmermann, Guenther Schellong, MD, Wolfgang Doerffel, MD, Reza Parwaresch, MD

Blood (2004) 104 (11): 3118.

https://doi.org/10.1182/blood.V104.11.3118.3118

Published: 2004

Journal Articles

Intensified Conditioning for Children Undergoing BMT for First Bone Marrow Relapse of Acute Lymphoblastic Leukaemia.

John Moppett, MD PhD, Jerry Hancock, PhD, Christopher J.C. Knechtli, MD PhD, Anthony Oakhill, MD, Nicholas J. Goulden, MD PhD

Blood (2004) 104 (11): 5169.

https://doi.org/10.1182/blood.V104.11.5169.5169

Published: 2004

Journal Articles

Diverse Functional Implications of ADAMTS13 Gene Mutations in Patients with TTP and Congenital Deficiency.

Roberta Donadelli, Biol.Sci.D, Federica Banterla, Biol.Sci.D, Cristina Capoferri, Biol.Sci.D, Miriam Galbusera, Biol.Sci.D, Zaverio M. Ruggeri, M.D., Sara Bucchioni, Biol.Sci.D, Marina Noris, Chem Pharm D, Giuseppe Remuzzi, M.D.

Blood (2004) 104 (11): 513.

https://doi.org/10.1182/blood.V104.11.513.513

Published: 2004

Journal Articles

Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2

Jeffrey S. Miller, Valarie McCullar

Blood (2001) 98 (3): 705–713.

https://doi.org/10.1182/blood.V98.3.705

Published: 2001

Journal Articles

TRA1, a Novel mRNA Highly Expressed in Leukemogenic Mouse Monocytic Sublines But Not in Nonleukemogenic Sublines

Takashi Kasukabe, Junko Okabe-Kado, Yoshio Honma

Blood (1997) 89 (8): 2975–2985.

https://doi.org/10.1182/blood.V89.8.2975

Published: 1997

NARROW

Phase 1b Dose Escalation Study of BI 836858 and Azacitidine in Previously Untreated AML: Results from Beat AML S2

Coupling Therapeutics to Human Erythrocytes Demonstrates Target-Dependent Effects on Red Cell Physiology While Preserving Efficacy

Clinical Exome Sequencing Unravels New Disease Causing Mutations in Myeloproliferative Neoplasms (MPNs): A Pilot Study in Patients from the State of Qatar

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

Analysis of WT1 Mutations and Combined Aberrations in Childhood Acute Myeloid Leukemia using Whole Exome Sequencing

Results of an AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Randomized Clinical Trial in Children with Low- and Intermediate-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Dual functions of cell-autonomous and non–cell-autonomous ADAM10 activity in granulopoiesis

Excellent Prognosis of Late Relapses of ETV6/RUNX1 Childhood Acute Lymphoblastic Leukemia: Lessons From the FRALLE 93 Protocol

Inotuzumab Ozogamycin (I0), a CD22 Monoclonal Antibody Conjugated to Calecheamicin, Is Active in Refractory-Relapse Acute Lymphocytic Leukemia (R-R ALL)

Glycoprotein Ibalpha Inhibitor Complex Crystal Structure at High Resolution.

Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors

Molecular Response to Treatment Predicts Outcome in Isolated, but Not in Combined Bone Marrow Relapses of Childhood Acute Lymphoblastic Leukaemia: Interim Results of Trial ALL-REZ BFM 2002

Structural and Functional Investigations of Active Site Binding Regions in Factor VIIa.

Variants of Recombinant Factor IX with Enhanced Functional Properties.

Influence of Multimer Size and a Natural Dimorphism on the Activity of Convulxin.

Proliferation Characteristics in Pediatric Hodgkin’s Disease Point to a Cell Cycle Arrest in G 1 Phase.

Intensified Conditioning for Children Undergoing BMT for First Bone Marrow Relapse of Acute Lymphoblastic Leukaemia.

Diverse Functional Implications of ADAMTS13 Gene Mutations in Patients with TTP and Congenital Deficiency.

Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2

TRA1, a Novel mRNA Highly Expressed in Leukemogenic Mouse Monocytic Sublines But Not in Nonleukemogenic Sublines

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only